In October, Ypsomed revealed YpsoDot, the pull & push self-injection pen for fixed doses up to 1 mL. Made from a single eco-material and following ecodesign principles from day one, the pen aims to reduce the environmental footprint.

On 21st October 2025 during PDA, Ypsomed launched YpsoLoop, the first autoinjector designed for circularity - enabling material recovery through automated disassembly and efficient recycling while offering injection guidance through ClickGuide^® technology and integrating into existing pharma supply chains.

CliniPilot brings connectivity to the YpsoMate and YpsoMate 2.25 mL platform, supporting decentralized study designs, EDC integration and real-time data capture.

Ypsomed introduces YpsoFlow, a spring-driven, pre-filled pen launched at CPHI China, designed for effortless injections and sustainability — advancing the company’s eco-design leadership in pen platforms.

Sustainability meets versatility: UnoPen becomes the latest Ypsomed platform available as a low-carbon device.

Ypsomed’s large-volume patch injector platform YpsoDose receives the Gold Award for Drug Delivery Innovation at CPHI China — recognizing its breakthrough role in redefining self-injection.

New needle configuration and strategic partnership with BD expand YpsoMate’s capabilities for high-viscosity biologics.

Expanding sustainability across platform sizes with a low-carbon solution for high-volume biologics.

Ypsomed showcases its upcoming reusable autoinjector concept at a leading industry forum.

Expanding digital health capabilities through therapy-specific patient solutions.

Digital therapeutics partnership to enhance patient support during self-injection.

Ypsomed redefines subcutaneous drug delivery with YpsoMate 5.5, allowing injection volumes up to 5.5 mL, following eco-design guidelines and offering continuous clicking.

Award-winning connectivity: SmartPilot for UnoPen recognized for design excellence.

Introduction the world’s first autoinjector for prefilled syringes with integrated connectivity.

Introduction of YpsoMate Zero the world's first zero carbon emission prefilled autoinjector.

Introduction of SmartPilot for UnoPen transforming the dial-and-dose UnoPen into a fully connected system.

First FixPen approval and launch for Teriparatide for treating osteoporosis.

Launch of Teva's Ajovy: The world's first approval and launch of a 2.25mL PFS based autoinjector.

Launch of 5 additional YpsoMate 1mL autoinjectors in key markets such as US, EU and JP including Teva's Copaxone and Asahi Kasei's Teribone.

First YpsoMate 1mL approval and launch for Mylan/FKB's Hulio (adalimumab) for the treatment of chronic autoimmune diseases.

Introduction of SmartPilot for YpsoMate transforming the proven YpsoMate autoinjector into a smart product system.

Introduction of an autoinjector suitable for 2.25ml syringes and viscous injection volumes up to 2.25ml. A high power constant force spring is capable to inject highly viscous formulations.

Introduction of an autoinjector suitable for the 2.25ml syringe and injection volumes up to 2.25ml.

Introduction of a customized version of LyoTwist Trio for AstraZeneca’s Bydureon-Pen.

Introduction of a customized version of LyoTwist Trio for GSK’s Tanzeum™/Eperzan^®.

Introduction and first launch of the prefilled UnoPen for insulin and other multidose therapies providing a familiar handling experience and high level of patient acceptance.

Launch of YpsoPen, the intuitive dial & dose reusable pen, for Dongbao's Sulin insulin

Introduction of a new 2-step “buttonless” autoinjector that sets new standards for simplicity and patient feedback. YpsoMate is currently being used by a number of customers for clinical trials in a range of therapeutic indications.

The first reusable automatic insulin pen that won the red dot design award, launched first as Gansulin Pen in China and in customized versions in other markets.

With this new generation of a disposable insulin pen, Ypsomed set a benchmark in the industry.

The world’s first pen for human growth hormone and for dual-chamber cartridges. With this pen Ypsomed built the foundation for pens compatible with dual-chamber cartridges.

As one of the world’s first insulin pens this pen is considered to be one of the forerunners of all following generations of insulin pens.